CVL237 Tablets for APDS/PASLI

Clinical trial NCT06293716 · UNKNOWN

Trial details

NCT number: NCT06293716
Sponsor: Convalife (Shanghai) Co., Ltd.
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

PI3K and P110delta Hyperactivation Syndrome

Start date: 2024-03-30
Primary completion: 2025-12-29
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.